MODERN APPROACHES TO THE THERAPY OF PSYCHOSOMATIC DISORDERS ASSOCIATED WITH CHRONIC DERMATOSES (literature review)

  • Authors: Melnik E.P.1, Dorozhenok I.Y.2,3, Kayumova L.N.4, Lomonosov K.M.4
  • Affiliations:
    1. Кафедра кожных венерических болезней ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский университет), 119435, г. Москва, Россия
    2. Department of Psychiatry and Psychosomatics, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991, Russian Federation
    3. Mental Health Research Center, Moscow, 115522, Russian Federation
    4. Department of skin and venereal diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119435, Russian Federation
  • Section: DERMATOLOGY
  • Submitted: 30.03.2025
  • Accepted: 20.08.2025
  • Published: 22.09.2025
  • URL: https://rjsvd.com/1560-9588/article/view/677845
  • DOI: https://doi.org/10.17816/dv677845
  • ID: 677845


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Abstract

A systematic literature review of approaches to the treatment of psychosomatic disorders associated with chronic dermatoses was conducted. Data from various studies are presented. This review analyzes the psychosomatic aspects of psoriasis, acne alopecia, lichen planus, vitiligo, including stress-induced mechanisms of their development and progression, the impact of stigmatization on the psycho-emotional state of patients, as well as their quality of life. Special attention is paid to nosogenic (secondary) and comorbid mental disorders associated with the main dermatological disease, such as anxiety-depressive disorders, social phobia and hypochondriac reactions. The expediency of using complex therapeutic strategies, including psychopharmacological correction (selective serotonin reuptake inhibitors, atypical antipsychotics, anxiolytics), cognitive behavioral therapy and psychoeducation programs, is substantiated. Multidisciplinary approaches to patient management are considered, including both dermatological correction and psychotherapeutic and psychopharmacological methods aimed at improving patient adaptation. 

The purpose of this article is to update information about the treatment of chronic dermatoses, including existing and new methods.

The information search was conducted in domestic and international databases of scientific literature: PubMed, Scopus, MedLine, Embase, Cochrane, the Russian State Library, the Central Scientific Medical Library of the I.M. Sechenov First Moscow State Medical University.

Full Text

Restricted Access

About the authors

Ekaterina Petrovna Melnik

Кафедра кожных венерических болезней ФГАОУ ВО «Первый Московский
государственный медицинский университет им. И.М. Сеченова» Минздрава России
(Сеченовский университет), 119435, г. Москва, Россия

Author for correspondence.
Email: katerina.melnik.5@gmail.com
ORCID iD: 0000-0002-2500-7861
SPIN-code: 7418-1995

Врач-аспирант кафедры кожных и венерических болезней им. В. А. Рахманова Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский университет), 119435, г. Москва, Россия.

Russian Federation, address: 4/1 Bolshaya Pirogovskaya street, 119435 Moscow, Russia

Igor Yuryevich Dorozhenok

Department of Psychiatry and Psychosomatics, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991, Russian Federation;

Mental Health Research Center, Moscow, 115522, Russian Federation

Email: idoro@bk.ru
ORCID iD: 0000-0003-1613-2510
SPIN-code: 8701-7958

Кандидат медицинских наук, доцент кафедры психиатрии и психосоматики Института клинической медицины им. Н.В.  Склифосовского ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский университет), 119991, г. Москва, Россия

Russian Federation

Lyailya Nailevna Kayumova

Department of skin and venereal diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119435, Russian Federation

Email: avestohka2005@inbox.ru
ORCID iD: 0000-0003-0301-737X
SPIN-code: 4391-9553

Кандидат  медицинских наук, доцент кафедры кожных и венерических болезней им. В. А. Рахманова института клинической медицины им. Н.В.  Склифосовского ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский университет), 119435, г. Москва, Россия

Russian Federation, address: 4/1 Bolshaya Pirogovskaya street, 119435 Moscow, Russia;

Konstantin Mikhailovich Lomonosov

Department of skin and venereal diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119435, Russian Federation

Email: lamclinic@yandex.ru
ORCID iD: 0000-0002-4580-6193
SPIN-code: 4784-9739

Доктор медицинских наук, профессор кафедры кожных и венерических болезней им. В. А. Рахманова института клинической медицины им. Н.В.  Склифосовского ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский университет), 119435, г. Москва, Россия

Russian Federation, address: 4/1 Bolshaya Pirogovskaya street, 119435 Moscow, Russia;

References

  1. Siddiqui Z, Felder E, Hernandez K, Loike-Weinstein D, Waseem M. The psychosocial impact of pediatric vitiligo, psoriasis, eczema, and alopecia: A systematic review. Bull Menninger Clin. 2024 Fall;88(4):297-319. doi: 10.1521/bumc.2024.88.4.297.
  2. Dorozhenok I.Yu. Nosogenic psychosomatic disorders in patients with skin diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(4-2):36-43. (In Russ.) doi: 10.17116/jnevro202312304236
  3. Liu L, Lin NX, Yu YT, Wang SH, Wang J, Cai XC, Wang CX, Zhang M, Li X, Li B. Epidemiology of mental health comorbidity in patients with psoriasis: An analysis of trends from 1986 to 2019. Psychiatry Res. 2023 Mar;321:115078. doi: 10.1016/j.psychres.2023.115078. Epub 2023 Jan 25. PMID: 36724650.
  4. Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, Misery L, Szabo C, Linder D, Sampogna F, Evers AWM, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015 Apr;135(4):984-991. doi: 10.1038/jid.2014.530. Epub 2014 Dec 18. PMID: 25521458; PMCID: PMC4378256.
  5. Bechman K, Hayes JF, Mathewman J, Henderson AD, Adesanya EI, Mansfield KE, Smith CH, Galloway J, Langan SM. Electronic screening for mental illness in patients with psoriasis. Br J Dermatol. 2023 Jul 17;189(2):246-248. doi: 10.1093/bjd/ljad141. PMID: 37224480; PMCID: PMC10351398.
  6. Chen Y, Sun S, Yang H, Fei X, Zhang Y, Song J, Ru Y, Zhao H, Luo Y, Kuai L, Luo Y, Li B, Xie M, Fan B, Ding X. Global prevalence of mental health comorbidity in patients with acne: An analysis of trends from 1961 to 2023. Clin Exp Dermatol. 2024 Dec 18:llae531. doi: 10.1093/ced/llae531. Epub ahead of print. PMID: 39692772.
  7. Molla A, Alrizqi H, Alharbi E, Alsubhi A, Alrizqi S, Shahada O. Assessment of Anxiety and Depression in Patients with Acne Vulgaris in Medina: A Case-Control Study. Clin Cosmet Investig Dermatol. 2021 Aug 6;14:999-1007. doi: 10.2147/CCID.S302311. PMID: 34385831; PMCID: PMC8354339.
  8. Lauron S, Plasse C, Vaysset M, Pereira B, D'Incan M, Rondepierre F, Jalenques I. Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata: A Systematic Review and Meta-analysis. JAMA Dermatol. 2023 Mar 1;159(3):281-288. doi: 10.1001/jamadermatol.2022.6085. PMID: 36696123; PMCID: PMC9878435.
  9. Lauron S, Plasse C, Vaysset M, Pereira B, D'Incan M, Rondepierre F, Jalenques I. Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata: A Systematic Review and Meta-analysis. JAMA Dermatol. 2023 Mar 1;159(3):281-288. doi: 10.1001/jamadermatol.2022.6085. PMID: 36696123; PMCID: PMC9878435.
  10. Cai XC, Wang SH, Wang CX, Liu L, Wang J, Shen YH, Li X. Epidemiology of mental health comorbidity in patients with atopic dermatitis: An analysis of global trends from 1998 to 2022. J Eur Acad Dermatol Venereol. 2024 Mar;38(3):496-512. doi: 10.1111/jdv.19686. Epub 2023 Dec 11. PMID: 38073580.
  11. Cai XC, Wang SH, Wang CX, Liu L, Wang J, Shen YH, Li X. Epidemiology of mental health comorbidity in patients with atopic dermatitis: An analysis of global trends from 1998 to 2022. J Eur Acad Dermatol Venereol. 2024 Mar;38(3):496-512. doi: 10.1111/jdv.19686. Epub 2023 Dec 11. PMID: 38073580.
  12. Jalenques I, Lauron S, Almon S, Pereira B, D'Incan M, Rondepierre F. Prevalence and Odds of Signs of Depression and Anxiety in Patients with Lichen Planus: Systematic Review and Meta-analyses. Acta Derm Venereol. 2020 Nov 24;100(18):adv00330. doi: 10.2340/00015555-3660. PMID: 33047148; PMCID: PMC9309823.
  13. Jalenques I, Lauron S, Almon S, Pereira B, D'Incan M, Rondepierre F. Prevalence and Odds of Signs of Depression and Anxiety in Patients with Lichen Planus: Systematic Review and Meta-analyses. Acta Derm Venereol. 2020 Nov 24;100(18):adv00330. doi: 10.2340/00015555-3660. PMID: 33047148; PMCID: PMC9309823.
  14. Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017 Sep;177(3):708-718. doi: 10.1111/bjd.15199. Epub 2017 Jul 23. PMID: 27878819.
  15. Alzeer, Faisal & Alajlan, Abdulmageed & Alshammari, Sulaiman & Ahamed, Shaik & Alzeer, Abdulaziz. (2023). Depression and Quality of Life among Saudi Patients with Vitiligo: A Descriptive Quantitative Review. The Open Dermatology Journal. 17. 10.2174/18743722-v17-e230907-2023-5.
  16. Kussainova A, Kassym L, Akhmetova A, Glushkova N, Sabirov U, Adilgozhina S, Tuleutayeva R, Semenova Y. Vitiligo and anxiety: A systematic review and meta-analysis. PLoS One. 2020 Nov 10;15(11):e0241445. doi: 10.1371/journal.pone.0241445. PMID: 33170870; PMCID: PMC7654800.
  17. Nasser, M.A., Raggi El Tahlawi, S.M., Abdelfatah, Z.A. et al. Stress, anxiety, and depression in patients with vitiligo. Middle East Curr Psychiatry 28, 63 (2021). https://doi.org/10.1186/s43045-021-00120-w
  18. Li V, Frasier K, Woolhiser E, Daly K, Christoforides S, Harpine C, Stech K, Acosta S, Lephart ED. Exploring the Intersection of Body Dysmorphic Disorder (BDD) and Dermatological Conditions: A Narrative Review. Dermatol Ther (Heidelb). 2024 Oct;14(10):2693-2708. doi: 10.1007/s13555-024-01256-3. Epub 2024 Sep 12. PMID: 39266863; PMCID: PMC11480305.
  19. Louise Lönndahl, Saly Abdelhadi, Mikael Holst, Sol-Britt Lonne-Rahm, Klas Nordlind, Björn Johansson. Psychological Stress and Atopic Dermatitis: A Focus Group Study Ann Dermatol 2023 Oct;35(5):342-347. doi: 10.5021/ad.22.035 .
  20. Dorozhenok I.Yu., Snarskaya E.S., Mikhailova M. Lichen planus and itch-related psychosomatic disorders // Russian Journal of Skin and Venereal Diseases. - 2021. - Vol. 24. - N. 6. - P. 543-551. (In Russ.) doi: 10.17816/dv100612
  21. Analysis of the DLQI quality of Life index (The Dermatology Life Quality Index) in patients with various dermatological nosologies / E. N. Efanova, E. A. Vasilyeva, N. V. Kobylyanskaya, M. A. Kalinin // Journal of scientific articles Health and Education in the XXI century. – 2019. – Vol. 21, № 6. – 22-26.– (In Russ.) doi: 10.26787/nydha-2226-7425-2019-21-6-22-26.
  22. Jeffrey R. Johns, Jui Vyas, Faraz M. Ali,1 John R. Ingram , Sam Salek and Andrew Y. Finlay. The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review // Br J Dermatol 2024; 191:497–507. doi: 10.1093/bjd/ljae228
  23. Hepat, A., Chakole, S., & Rannaware, A. (2023). Psychological well-being of adult psoriasis patients: A narrative review. Cureus. doi: 10.7759/cureus.37702
  24. Brittany Blackstone , Radhika Patel Anthony Bewley Assessing and Improving Psychological Well-Being in Psoriasis: Considerations for the Clinician //Psoriasis: Targets and Therapy Volume 2022:12 Pages 25—33. doi: 10.2147/PTT.S328447
  25. Nowowiejska J, Baran A, Grabowska P, Lewoc M, Kaminski TW, Flisiak I: Assessment of life quality, stress and physical activity among patients with psoriasis. Dermatol Ther. 2022, 12:395-406. doi: 10.1007/s13555-021-00662-1
  26. Haddad A, Zisman D. Comorbidities in Patients with Psoriatic Arthritis. Rambam Maimonides Med J 2017;8 (1):e0004. doi: 10.5041/RMMJ.10279 Review.
  27. Soliman MM: Depressive, anxiety, stress, and insomnia symptoms in patients with psoriasis: a crosssectional study. Adv Dermatol Allergol 2021; XXXVIII (3): 510–519. doi: 10.5114/ada.2020.98726
  28. Lakshmy S, Balasundaram S, Sarkar S, Audhya M, Subramaniam E: A cross-sectional study of prevalence and implications of depression and anxiety in psoriasis. Indian J Psychol Med. 2015, 37:434-40. doi: 10.4103/0253- 7176.168587
  29. López-Mejía R, Ramales-Montes EM, Ley-Silva LS, Romero-Sansalvador CY, Gutiérrez-Gabriel I: Quality of life, depression and its relation to the severity in psoriasis. Rev Med Inst Mex Seguro Soc. 2022, 60:315-20.
  30. Schmitt J, Ford DE. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach. Gen Hosp Psychiatry. 2007 Mar-Apr;29(2):134-40. doi: 10.1016/j.genhosppsych.2006.12.004.
  31. Dorozhenok I. Yu., Ilina E.V. Psychosomatic aspects of psoriasis (review). Russian Journal of Skin and Venereal Diseases. 2021;24(3):251–262. (In Russ.) doi: 10.17816/dv71927
  32. Alpsoy E, Ozcan E, Cetin L, Ozgur O, Er H, Yilmaz E, Karaman T. Is the efficacy of topical corticosteroid therapy for psoriasis vulgaris enhanced by concurrent moclobemide therapy? A double-blind, placebo-controlled study. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):197-200. doi: 10.1016/s0190-9622(98)70240-3.
  33. Sukharev A.V., Patrushev A.V., Nazarov R.N., Gutka V.O. The possibilities of using new generation antidepressants to correct psychosomatic disorders in chronic dermatoses "Effective pharmacotherapy". Dermatovenerology and dermatocosmetology" No. 2 (19). (In Russ.)
  34. Potekaev N.N., Lvov A.N. , Zhukova O.V., Khlystova E.A., Kochetkov M.A. , Igoshina A.V. / Psychosomatic disorders and quality of life in chronic fascial dermatoses and their dynamics against the background of the use of medical camouflage // Clinical dermatology and venereology. - 2017 - №. 5. - 58-72. (In Russ.)
  35. Smulevich A.B., Dorozhenok I.Yu., Romanov D.V., Lvov A.N. ; under the general editorship of A. B. Smulevich. Psychopathology of mental disorders in a dermatological clinic (a model of mental pathology limited by the space of the skin): monograph "Psychosomatic disorders in clinical practice", / – M., 2014. – 350-373. (In Russ.)
  36. Il’chevskaya E.A., Krinitsyna Y.M., Sergeeva I.G. Abnormalities of Psycho-Emotional State among Patients with Excoriated Acne // Vestnik dermatologii i venerologii. - 2017. - Vol. 93. - N. 5. - P. 64-69. (In Russ.) doi: 10.25208/0042-4609-2017-93-5-64-69
  37. Volkova N.V., Glazkova L.K., K.Y. Retyunsky. Therapeutic and diagnostic algorithm for the management of acne patients with comorbid mental disorders // Ural Medical Journal, 2013, №. 8. – 68 -73. (In Russ.)
  38. Romanova Yu. Yu., Romanov D.V., Brazhnikov А.Yu., Voronova E.I., Lvov A.N., Potekaev N.N.. Perspective targets for secondary prevention of quality of life decrease and psychosomatic disorders in alopecia: results of an observational study. Russian Journal of Preventive Medicine. 2019;22(5):104‑111. (In Russ.) doi: 10.17116/profmed201922051104
  39. Michenko A.B., Lvov A.N. Psychosomatic aspects of atopic dermatitis: classical canons and new concepts // Russian Journal of Skin and Venereal Diseases. – 2008; 4: 11–18. (In Russ.)
  40. Potekaev N.N., Danilin I., Korsunskaya I., Kostolevskaya A., Nezpinskaya Z., Artemyeva M. PSYCHOSOMATIC ASPECTS OF ATOPIC DERMATITIS. Doctor, 2018; (2): 16-20 (In Russ.)
  41. Fiocco Z, Kupf S, Patzak L, Kämmerer T, Pumnea T, French LE, Reinholz M. Quality of Life and Psychopathology in Lichen Planus: A Neglected Disease Burden. Acta Derm Venereol. 2021 Dec 14;101(12):adv00619. doi: 10.2340/actadv.v101.442.
  42. Arnold S, Fernando S, Rees S. Living with vulval lichen sclerosus: a qualitative interview study. Br J Dermatol. 2022;187(6):909–918. doi: 10.1111/ bjd.21777
  43. Nasimi M, Ahangari N, Lajevardi V, et al. The quality of life and mental health status in patients with lichen planopilaris based on dermatology life quality index and general health questionnaire-28 questionnaires. Int J WomensDermatol. 2020;6(5):399–403. doi: 10.1016/j.ijwd.2020.09.005
  44. Perlamutrov Yu.N., Olkhovskaya K.B., Vasilenko T.I., Anokhina D.I. Lichenoid dermatoses of the anogenital area. Russian Journal of Clinical Dermatology and Venereology. 2022;21(5):646-654. (In Russ.) doi: 10.17116/klinderma202221051646
  45. Adamo, D.; Calabria, E.; Coppola, N.; Lo Muzio, L.; Giuliani, M.; Bizzoca, M.E.; Azzi, L.; Croveri, F.; Colella, G.; Boschetti, C.E.; et al. Psychological profile and unexpected pain in oral lichen planus: A case-control multicenter SIPMO studya. Oral Dis. 2021,Jan 29, 28, 398–414. . doi: 10.1111/odi.13787.
  46. Tlish M.M., Osmolovskaya P.S. Optimization of therapy in patients with lichen ruber planus by means of cranial electrotherapy stimulation // Almanac of Clinical Medicine. - 2021. - Vol. 49. - N. 8. - P. 516-524. (In Russ.) doi: 10.18786/2072-0505-2021-49-046
  47. Gaitán-Cepeda, L.A.; Rivera-Reza, D.I.; Villanueva-Vilchis, M.d.C. Neuroticism and Psychological Stress in Patients Suffering Oral Lichen Planus: Research Evidence of Psycho-Stomatology? Healthcare 2023, 11, 1738. https://doi.org/10.3390/ healthcare11121738
  48. Dorozhenok I.Yu., Snarskaya E.S., Shenberg V.G. Comorbid mental disorders in patients with lichen planus // Russian Journal of Skin and Venereal Diseases. - 2015. - Vol. 18. - N. 5. - P. 38-42. (In Russ.) doi: 10.17816/dv36997
  49. Bibeau, K., Ezzedine, K., Harris, J. E., van Geel, N., Grimes, P., Parsad, D., Tulpule, M., Gardner, J., Valle, Y., Tlhong Matewa, G., LaFiura, C., Lindley, A., Ren, H., & Hamzavi, I. H. (2023). Mental health and psychosocial quality-of-life burden among patients with Vitiligo. JAMA Dermatology, 159(10), 1124. doi: 10.1001/jamadermatol.2023.2787
  50. Zhang Y., Cai Y., Shi M., et al. The Prevalence of Vitiligo: A Meta-Analysis. PLoS One. 2016; 11(9): e0163806. doi: 10.1371/journal.pone.0163806
  51. Naldi L, Pagani A, Alduini C. Vitiligo: Epidemiology and Economic Impact. Dermatol Pract Concept. 2023 Dec 1;13(4S2):e2023315S. doi: 10.5826/dpc.1304S2a315S.
  52. Picardo M, Huggins RH, Jones H, Marino R, Ogunsola M, Seneschal J. The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes.J Eur Acad Dermatol Venereol. 2022;36(9):1507-1523. doi: 10.1111/jdv.18129
  53. Augustin M, Gewiss C, Ben-Anaya N, Böhm M. Lebensqualität, Krankheitslast und Versorgungsbedarf von Patienten mit Vitiligo [Quality of life, disease burden and healthcare need of patients with vitiligo]. Dermatologie (Heidelb). 2024 May;75(5):404-411. German. doi: 10.1007/s00105-024-05312-z.
  54. Morrison B, Burden-Teh E, Batchelor JM, Mead E, Grindlay D, Ratib S. Quality of life in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2017 Dec;177(6):e338-e339. doi: 10.1111/bjd.15933.
  55. Cupertino F, Niemeyer-Corbellini JP, Ramos-E-Silva M. Psychosomatic aspects of vitiligo. Clin Dermatol. 2017 May-Jun;35(3):292-297. doi: 10.1016/j.clindermatol.2017.01.001. Epub 2017 Jan 21. PMID: 28511827.
  56. Alharbi MA. Identifying Patients at Higher Risk of Depression Among Patients with Vitiligo at Outpatient Setting. Mater Sociomed. 2020 Jun;32(2):108-111. doi: 10.5455/msm.2020.32.108-111.
  57. Al-Janabi MAK, Dorozhenok I.Yu., Lomonosov K.M. Psychosomatic aspects of vitiligo. A review of the literature. Russian journal of skin and venereal diseases. 2023;26(6):597–603. (in Russ.)doi: 10.17816/dv487099.
  58. Dahir AM, Thomsen SF. Comorbidities in vitiligo: Comprehensive review. Int J Dermatol. 2018;57(10):1157–1164. doi: 10.1111/ijd.14055 11.
  59. Bonotis K, Pantelis K, Karaoulanis S, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges. 2016;14(1):45–49. doi: 10.1111/ddg.12729
  60. Ezzedine, K., Eleftheriadou, V., Jones, H. et al. Psychosocial Effects of Vitiligo: A Systematic Literature Review. Am J Clin Dermatol 22, 757–774 (2021). doi: 10.1007/s40257-021-00631-6
  61. Sarkar S, Sarkar T, Sarkar A, Das S. Vitiligo and Psychiatric Morbidity: A Profile from a Vitiligo Clinic of a Rural-based Tertiary Care Center of Eastern India // Indian journal of dermatology. 2018 Jul-Aug;63(4):281-284. doi: 10.4103/ijd.IJD_142_18.
  62. Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta‐analysis. The British journal of dermatology. 2018;178(4):863‐878. doi: 10.1111/bjd.16049
  63. Carniciu, S., Ha, B., Gkini, M. ‐A., Tzellos, T., Jaerany, M., & Stamu‐O’Brien, C. (2023). Secondary psychiatric disorders and the skin. Dermatological Reviews, 4(4), 162–171. doi: 10.1002/der2.211
  64. Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F. Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population. Health Qual Life Outcomes. 2020 Feb 3;18(1):20. doi: 10.1186/s12955-020-1278-7.
  65. Wang KY, Wang KH, Zhang ZP. Health related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2011;25(4):429-435. doi: 10.1111/j.1468-3083.2010.03808x
  66. Catucci Boza J, Giongo N, Machado P, Horn R, Fabbrin A, Cestari T. Quality of life impairment in children and adults with vitiligo: a cross-sectional study based on dermatology-specific and discase specific quality of life instruments. Dermatology. 2016;232(5):619-625. doi: 10.1159/000448656
  67. Dertlioglu SB, Cicek D. Balci DD, Halisdemir N. Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects. Int J Dermatol. 2013;52(1): 96-101. doi: 10.1111/j.1365-4632.2012.05616x
  68. Krüger C, Panske A, Schallreuter KU. Discase-related behavioral patterns and experiences affect quality of ife in children and adolescents with vitiligo. Int J Dermatol. 2014;53(1):43-50. doi: 10.1111/j.1365-4632.2012.05656x
  69. Linthorst Homan MW, de Korte J, Grootenhuis MA, Bos JD. Sprangers MAG, van der Veen JPW. Impact of childhood vitiligo on adult life. Br J Dermatol. 2008;159(4):915-920. doi: 10.1111/j.1365-2133.2008.08788.x
  70. Varzhapetyan A.A., Dorozhenok I.Yu., Lomonosov K.M. Vitiligo and comorbid psychosomatic disordes. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei). 2019; 22(1–2): 33-38. (in Russian).
  71. Davletshina A.Yu., Lomonosov K.M. Prospective methods of vitiligo treatment (literature review). Russian Journal of Skin and Veneral Diseases. Russian Journal (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei). 2019; 22(1–2): 56-60. (in Russian)
  72. Koshenko Yu.N. Vitiligo. Clinic, etiology, pathogenesis, treatment, rehabilitation, prevention. – M.: “Cosmetics and Medicine”, 2002. 492-500. (in Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г.